Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison

被引:0
作者
Nash, Peter [1 ]
McInnes, Iain B. [2 ]
Mease, Philip J. [3 ,4 ]
Choy, Ernest H. [5 ,6 ]
Thom, Howard [7 ]
Kalyvas, Chrysostomos [8 ]
Gandhi, Kunal [9 ]
Mpofu, Shephard [10 ]
Jugl, Steffen [10 ]
机构
[1] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Cardiff Univ, Sch Med, Rheumatol Sect, Cardiff, S Glam, Wales
[6] Cardiff Univ, CREATE Ctr, Div Infect & Immun, Cardiff, S Glam, Wales
[7] Univ Bristol, Bristol, Avon, England
[8] MAPI Grp, Houten, Netherlands
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1738
引用
收藏
页数:2
相关论文
共 50 条
[31]   MATCHING-ADJUSTED INDIRECT COMPARISON OF IXEKIZUMAB VS. TOFACITINIB IN PSORIATIC ARTHRITIS [J].
Sapin, C. ;
Panni, T. ;
Meszaros, G. ;
Hill, J. ;
Hartz, S. .
VALUE IN HEALTH, 2020, 23 :S593-S593
[32]   Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on Pivotal Phase 3 Clinical Trial Data [J].
Maksymowych, Walter ;
Strand, Vibeke ;
Nash, Peter ;
Thom, Howard ;
Karabis, Andreas ;
Gandhi, Kunal ;
Porter, Brian ;
Jugl, Steffen .
JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) :914-915
[33]   INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITIS [J].
Kirson, N. ;
Rao, S. ;
Birnbaum, H. G. ;
Kantor, E. ;
Wei, R. ;
Cifaldi, M. .
VALUE IN HEALTH, 2011, 14 (03) :A129-A130
[34]   COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND ADALIMUMAB IN ANKYLOSING SPONDYLITIS AS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON: AN ANALYSIS BASED ON ALL PIVOTAL PHASE 3 CLINICAL TRIAL DATA [J].
Maksymowych, W. P. ;
Walsh, J. ;
Thom, H. ;
Kalyvas, C. ;
Rosal, G. F. ;
Porter, B. ;
Gandhi, K. ;
Jugl, S. M. .
VALUE IN HEALTH, 2017, 20 (09) :A935-A935
[35]   Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis As Assessed By Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data [J].
Maksymowych, Walter P. ;
Strand, Vibeke ;
Nash, Peter ;
Thom, Howard ;
Karabis, Andreas ;
Gandhi, Kunal ;
Porter, Brian ;
Jugl, Steffen .
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[36]   Secukinumab versus adalimumab for psoriatic arthritis [J].
Thorley, Jennifer .
LANCET RHEUMATOLOGY, 2020, 2 (06) :E322-E322
[37]   Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data [J].
Maksymowych, Walter P. ;
Choy, Ernest ;
Yazici, Yusuf ;
Walsh, Jessica A. ;
Thom, Howard ;
Kalyvas, Chrysostomos ;
Fox, Todd ;
Gandhi, Kunal ;
Jugl, Steffen .
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[38]   COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA [J].
Tahir, Hasan ;
Maksymowych, Walter ;
Choy, Ernest ;
Yazici, Yusuf ;
Walsh, Jessica ;
Thom, Howard ;
Kalyvas, Chrysostomos ;
Fox, Todd ;
Gandi, Kunal ;
Jugl, Steffen .
RHEUMATOLOGY, 2018, 57
[39]   COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA [J].
Maksymowych, W. ;
Choy, E. ;
Yazici, Y. ;
Walsh, J. ;
Thom, H. ;
Kalyvas, C. ;
Fox, T. ;
Gandhi, K. ;
Jugl, S. .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :1301-1301
[40]   COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND ADALIMUMAB IN ANKYLOSING SPONDYLITIS (AS) AS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC): AN ANALYSIS BASED ON ALL PIVOTAL PHASE 3 CLINICAL TRIAL DATA [J].
Nash, P. ;
Maksymowych, W. ;
Strand, V ;
Thom, H. ;
Karabis, A. ;
Gandhi, K. ;
Porter, B. ;
Jugl, S. .
INTERNAL MEDICINE JOURNAL, 2017, 47 :38-38